Post-stroke infection: a role for IL-1ra?

Neurocrit Care. 2011 Apr;14(2):244-52. doi: 10.1007/s12028-010-9490-7.

Abstract

Background: Infection is common following stroke and is independently associated with worse outcome. Clinical studies suggest that infections occur more frequently in those individuals with stroke-induced immunologic dysfunction. This study sought to explore the contribution of immunomodulatory cytokines and hormones to lymphocyte function and infection risk.

Methods: Patients (N = 112) were enrolled as soon as possible after the onset of ischemic stroke. Blood was drawn to assess plasma cortisol, IL-10, IL-1ra, lymphocyte numbers, and lymphocyte function at 72 h after stroke onset; infections were censored through 21 days after stroke onset.

Results: Infection occurred in 25% of patients. Stroke severity was the most important predictor of infection risk. Increased plasma cortisol, IL-10, and IL-1ra, as well as decreased lymphocyte numbers, at 72 h after stroke onset were associated with risk of subsequent infection. After controlling for stroke severity, only IL-1ra was independently associated with infection risk, and the degree of risk was consistent throughout the post-stroke period. Infection, but not IL-1ra itself, was associated with worse outcome at 3 months.

Conclusions: In this study cohort, increased plasma IL-1ra was independently associated with the risk of post-stroke infection. Further studies are needed to validate this finding, which could have important implications for stroke therapy.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Cohort Studies
  • Critical Care
  • Female
  • Humans
  • Hydrocortisone / blood
  • Hydrocortisone / immunology
  • Infections / epidemiology*
  • Infections / immunology*
  • Interleukin 1 Receptor Antagonist Protein / blood
  • Interleukin 1 Receptor Antagonist Protein / immunology*
  • Male
  • Middle Aged
  • Risk Factors
  • Severity of Illness Index
  • Stroke / epidemiology*
  • Stroke / immunology*

Substances

  • Interleukin 1 Receptor Antagonist Protein
  • Hydrocortisone